Charles Porter

Wayne Weisman has been a partner at SCP since its inception and his experience in private equity and venture capital investing dates to 1987. He joined Churchill Investment Partners, Inc. as a managing director in 1990, and became Vice President and a member of the board of directors of CIP Capital at its founding. From 1992 to 1994 he served as Executive Vice President of Affinity Biotech, Inc. where he had responsibility for strategic alliances, financial strategy, and mergers and acquisitions and oversaw its IPO and merger into the company that became IBAH, Inc. From 1987 to 1990, Wayne operated a management and financial advisory firm. Wayne began his career at the Philadelphia law firm of Saul, Ewing, Remick & Saul. He is a director or chairman of several companies, including CinemaStar, Inc., Gigared S.A. and Deep Breeze, Ltd, and he was until recently a director of Auxilium Pharmaceuticals, Inc. He also serves on the investment committee of Vitalife Life Sciences Fund. Wayne graduated cum laude with a BA from the University of Pennsylvania. He received a JD from the University of Michigan Law School.